Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › FL › Tampa › NPI 1255314704
Lab

Laboratory Corporation of America

Laboratory Corporation of America was paid $171.13M by Medicaid between Jan 2018 and Dec 2024, across 582 billing codes. Its largest line is 87491, Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe — 6.3% of everything it billed.

33Billing provider infoLABORATORY CORPORATION OF AMERICA
TAMPA, FL 33607
33aNPI1255314704assigned 11/29/2005
33bProvider typeClinical Medical Laboratory
28Total paid$171.13M
24GClaims37,608,686
24DCodes billed582
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Clinical Medical Laboratory providers in Florida

Rank by total paid#2 of 225
Median peer was paid$74K
This provider vs. median2,327×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official WILLIAMS, KIMBERLY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$2.0M$4.0M$6.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018623,256$1.16M
20195,236,987$15.75M
20205,688,485$18.25M
20216,767,231$26.62M
20226,651,991$40.28M
20237,352,473$41.61M
2024incomplete5,288,263$27.46M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 6.3% 1,030,420 956,027 $10.72M
80050 General health panel 5.3% 496,792 477,509 $9.02M
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 4.9% 959,420 860,136 $8.34M
81420 Fetal chromosomal aneuploidy genomic sequence analysis panel 4.5% 33,077 31,551 $7.65M
81220 CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants 4.1% 39,146 37,386 $7.08M
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 3.9% 1,018,379 944,853 $6.63M
80061 Lipid panel 3.5% 2,290,845 2,035,213 $6.04M
85025 Blood count; complete (CBC), automated, and automated differential WBC count 3.2% 2,309,810 2,010,483 $5.46M
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 3.1% 253,156 167,080 $5.33M
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 2.9% 78,302 68,050 $4.96M
80053 Comprehensive metabolic panel 2.8% 2,425,103 2,047,307 $4.83M
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 2.6% 635,507 602,344 $4.48M
570 more codes
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 2.3% 249,634 $4.00M
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms 2.3% 195,332 $3.94M
88305 Level IV - Surgical pathology, gross and microscopic examination 2.2% 101,347 $3.81M
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer 1.8% 353,994 $3.05M
84443 Thyroid stimulating hormone (TSH) 1.8% 1,477,663 $3.01M
80081 1.7% 97,356 $2.99M
83036 Hemoglobin; glycosylated (A1C) 1.5% 1,604,384 $2.50M
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1.4% 118,858 $2.46M
84439 1.4% 732,391 $2.40M
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 1.3% 294,961 $2.15M
80074 1.2% 135,851 $2.08M
87536 1.1% 73,363 $1.93M
87086 Culture, bacterial; quantitative colony count, urine 1.1% 820,548 $1.81M
86003 1.0% 94,324 $1.76M
80055 1.0% 18,123 $1.72M
82607 <1% 564,832 $1.71M
86480 <1% 82,764 $1.55M
85027 <1% 397,028 $1.54M
86360 <1% 92,840 $1.39M
86803 <1% 361,334 $1.35M
86235 <1% 47,821 $1.08M
82728 <1% 312,692 $1.06M
82746 <1% 464,021 $961K
81001 <1% 956,340 $953K
87081 <1% 355,074 $913K
84403 <1% 132,870 $911K
86769 <1% 38,101 $885K
84402 <1% 74,388 $642K
84153 <1% 227,026 $628K
83655 <1% 213,765 $621K
81229 <1% 3,353 $601K
87186 <1% 238,213 $593K
87340 <1% 287,674 $592K
84702 <1% 149,459 $565K
82670 <1% 64,738 $562K
86592 <1% 559,549 $548K
83550 <1% 290,833 $509K
82570 <1% 531,419 $489K
83970 <1% 73,340 $485K
88342 <1% 17,136 $482K
83001 <1% 102,195 $466K
87522 Neg quan hep c or qual rna <1% 24,343 $465K
84481 <1% 85,484 $460K
88312 <1% 17,029 $432K
81003 <1% 538,087 $416K
84146 <1% 84,849 $397K
83540 <1% 352,930 $393K
82043 <1% 513,149 $393K
87070 <1% 134,894 $367K
86361 <1% 31,325 $362K
87480 <1% 35,698 $360K
82784 <1% 80,321 $352K
86696 <1% 68,765 $352K
86359 <1% 26,723 $351K
83002 <1% 92,180 $330K
84436 <1% 312,181 $329K
83013 <1% 31,638 $321K
87150 <1% 58,073 $320K
83516 <1% 35,279 $319K
81329 <1% 17,865 $309K
87088 <1% 232,511 $300K
86038 <1% 107,484 $294K
84480 <1% 104,324 $288K
88142 <1% 34,042 $287K
81243 <1% 17,005 $287K
86787 <1% 77,876 $277K
83020 <1% 58,602 $277K
82274 <1% 126,387 $276K
80048 Basic metabolic panel (calcium, ionized) <1% 171,912 $274K
88141 <1% 52,176 $270K
82950 <1% 190,520 $266K
86762 <1% 85,384 $266K
82951 <1% 45,635 $255K
88341 <1% 6,684 $253K
87901 <1% 1,772 $245K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 37,548 $243K
86317 <1% 33,937 $242K
36415 Collection of venous blood by venipuncture <1% 947,942 $242K
83525 <1% 94,718 $235K
86140 <1% 182,602 $233K
87902 <1% 3,216 $222K
86695 <1% 63,722 $216K
83021 <1% 39,381 $209K
86364 <1% 22,050 $203K
84144 <1% 39,594 $197K
87209 <1% 56,327 $194K
88185 <1% 1,797 $194K
86376 <1% 72,585 $191K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B <1% 3,478 $188K
83880 <1% 23,119 $188K
87535 <1% 7,994 $187K
87077 <1% 144,071 $186K
87563 <1% 28,373 $183K
82040 <1% 109,338 $179K
81443 <1% 318 $174K
85660 <1% 109,130 $174K
82627 <1% 35,034 $169K
82977 <1% 66,385 $167K
87045 <1% 41,088 $167K
87529 <1% 11,982 $159K
86225 <1% 40,524 $158K
86850 <1% 100,655 $157K
84445 <1% 9,252 $155K
86800 <1% 46,693 $155K
80076 <1% 97,548 $155K
82652 <1% 46,131 $154K
82105 <1% 72,902 $152K
84305 <1% 16,277 $151K
82785 <1% 70,174 $149K
86665 <1% 16,045 $143K
84479 <1% 169,034 $142K
86147 <1% 10,288 $139K
83735 <1% 112,100 $137K
83521 <1% 9,946 $135K
87660 <1% 37,485 $132K
84550 <1% 232,880 $128K
83520 <1% 19,431 $126K
87427 <1% 40,857 $121K
88304 <1% 7,735 $119K
86706 <1% 60,291 $115K
82378 <1% 37,305 $115K
85610 <1% 165,867 $114K
86780 <1% 39,995 $113K
85730 <1% 116,803 $110K
86704 <1% 49,801 $109K
80347 <1% 50,891 $105K
86160 <1% 31,348 $104K
85652 <1% 215,271 $103K
82024 <1% 8,293 $101K
84681 <1% 19,604 $100K
87510 <1% 34,529 $99K
82565 <1% 140,542 $99K
84466 <1% 27,575 $99K
86008 <1% 8,685 $98K
80348 <1% 57,648 $98K
80354 <1% 58,287 $95K
86300 <1% 17,114 $92K
86431 <1% 79,241 $92K
82533 <1% 23,029 $91K
86356 <1% 6,692 $91K
87177 <1% 56,467 $91K
86146 <1% 6,748 $89K
87625 <1% 7,807 $89K
80359 <1% 54,471 $87K
84165 <1% 27,160 $86K
88112 <1% 9,236 $85K
87517 <1% 4,533 $85K
86200 <1% 32,082 $83K
84450 <1% 128,138 $83K
83498 <1% 14,901 $83K
82947 <1% 162,776 $82K
84156 <1% 108,166 $80K
80361 <1% 54,339 $78K
81257 <1% 3,117 $78K
83090 <1% 48,206 $77K
85060 <1% 6,471 $77K
80069 <1% 40,257 $77K
80365 <1% 54,095 $76K
80373 <1% 50,008 $75K
82247 <1% 116,195 $73K
80372 <1% 49,431 $73K
80358 <1% 60,925 $73K
86258 <1% 10,231 $72K
83921 <1% 10,041 $72K
81479 Unlisted molecular pathology procedure <1% 360 $71K
86341 <1% 4,122 $70K
88262 <1% 3,858 $69K
87075 <1% 24,660 $69K
80353 <1% 54,407 $69K
85014 <1% 47,117 $68K
80164 <1% 20,163 $68K
83615 <1% 81,564 $68K
80324 <1% 31,758 $67K
82672 <1% 13,014 $66K
86355 <1% 6,785 $66K
87338 <1% 26,993 $65K
86304 <1% 17,430 $64K
84075 <1% 110,870 $64K
80197 <1% 18,668 $64K
86900 <1% 91,921 $64K
84520 <1% 126,935 $64K
86765 <1% 22,071 $63K
82310 <1% 100,446 $63K
86708 <1% 33,273 $62K
81374 <1% 5,050 $62K
84100 <1% 87,756 $61K
82150 <1% 38,930 $61K
82248 <1% 61,436 $61K
84154 <1% 34,647 $59K
83690 <1% 48,597 $59K
86334 <1% 18,162 $59K
84703 <1% 29,931 $57K
88184 <1% 1,542 $56K
82626 <1% 4,686 $55K
87799 <1% 4,661 $52K
82550 <1% 46,660 $51K
85007 <1% 12,537 $50K
84295 <1% 88,351 $50K
84155 <1% 117,406 $50K
88307 <1% 467 $50K
87046 <1% 41,884 $49K
85245 <1% 6,456 $49K
82435 <1% 90,081 $49K
84207 <1% 6,015 $47K
84132 <1% 90,596 $47K
86735 <1% 21,193 $47K
83993 <1% 10,837 $46K
84460 <1% 66,242 $46K
82157 <1% 4,916 $46K
84425 <1% 8,436 $45K
88313 <1% 2,039 $45K
87497 <1% 4,378 $41K
87329 <1% 15,246 $40K
81364 <1% 591 $40K
86677 <1% 4,217 $40K
86664 <1% 12,395 $39K
84270 <1% 10,494 $39K
86901 <1% 91,749 $39K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 1,946 $39K
86141 <1% 16,592 $38K
99199 Unlisted special service, procedure or report <1% 7,964 $38K
88230 <1% 3,895 $36K
85045 <1% 52,940 $36K
85246 <1% 6,930 $35K
85379 <1% 5,900 $35K
87324 <1% 11,468 $34K
86702 <1% 9,732 $34K
86777 <1% 10,948 $34K
86301 <1% 8,566 $34K
87900 <1% 2,048 $34K
82610 <1% 5,245 $33K
82952 <1% 38,127 $33K
80051 <1% 26,408 $31K
82140 <1% 10,361 $31K
81490 <1% 349 $31K
86037 <1% 3,698 $31K
83721 <1% 35,726 $30K
82787 <1% 3,703 $30K
86381 <1% 3,816 $29K
84410 <1% 1,350 $29K
81209 <1% 1,831 $29K
82653 <1% 2,053 $28K
81377 <1% 1,204 $27K
81596 <1% 2,895 $27K
82330 <1% 12,870 $27K
80177 <1% 8,951 $27K
81361 <1% 1,452 $27K
82088 <1% 2,821 $27K
86357 <1% 4,476 $26K
84482 <1% 2,617 $26K
82239 <1% 4,519 $25K
85240 <1% 7,032 $25K
86231 <1% 9,938 $25K
86709 <1% 12,011 $25K
86778 <1% 7,511 $25K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 3,466 $25K
82397 <1% 4,756 $24K
85018 <1% 61,163 $23K
87538 <1% 3,156 $23K
84630 <1% 9,155 $22K
84134 <1% 5,585 $22K
86644 <1% 8,062 $22K
82668 <1% 7,382 $22K
84432 <1% 3,979 $22K
86015 <1% 4,479 $22K
86870 <1% 4,411 $22K
86335 <1% 3,696 $22K
83010 <1% 9,996 $21K
86645 <1% 6,891 $21K
86593 <1% 19,074 $21K
82103 <1% 7,737 $20K
80202 <1% 5,179 $20K
82731 <1% 923 $20K
81408 <1% 234 $20K
87906 <1% 1,490 $20K
87101 <1% 8,368 $19K
82465 <1% 57,128 $19K
86701 <1% 9,007 $19K
84166 <1% 6,110 $19K
85004 <1% 5,045 $19K
82677 <1% 19,409 $18K
86705 <1% 9,493 $18K
86747 <1% 2,089 $17K
87507 <1% 1,035 $17K
82542 <1% 1,867 $17K
83883 <1% 6,826 $17K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed <1% 1,070 $16K
80178 <1% 9,653 $16K
80349 <1% 3,691 $15K
84590 <1% 5,376 $15K
81241 <1% 2,372 $15K
81025 <1% 8,325 $14K
87184 <1% 6,050 $14K
83835 <1% 1,246 $14K
82232 <1% 4,684 $14K
86337 <1% 2,388 $14K
82679 <1% 1,485 $14K
82104 <1% 3,246 $14K
86255 <1% 8,616 $14K
87255 <1% 2,296 $14K
82390 <1% 7,501 $14K
81255 <1% 1,804 $14K
86618 <1% 3,099 $13K
80299 <1% 1,749 $13K
88189 <1% 1,256 $13K
85597 <1% 1,940 $13K
86162 <1% 6,174 $13K
82575 <1% 5,573 $13K
G0103 Prostate cancer screening; prostate specific antigen test (psa) <1% 15,180 $13K
86663 <1% 4,016 $13K
86694 <1% 5,785 $12K
82085 <1% 5,773 $12K
82172 <1% 2,782 $12K
84080 <1% 3,532 $12K
80156 <1% 4,290 $11K
84478 <1% 21,844 $11K
87210 <1% 3,350 $11K
86336 <1% 20,068 $11K
81251 <1% 1,482 $11K
81270 <1% 439 $11K
82985 <1% 6,679 $11K
85041 <1% 16,734 $11K
82525 <1% 4,073 $11K
84244 <1% 2,940 $10K
81240 <1% 1,425 $10K
81200 <1% 1,514 $10K
83718 <1% 22,147 $10K
85048 <1% 17,426 $10K
85306 <1% 2,060 $10K
82374 <1% 8,426 $10K
85598 <1% 2,953 $9K
87521 Neg quan hep c or qual rna <1% 1,625 $9K
85384 <1% 3,993 $9K
86617 <1% 833 $9K
87999 <1% 388 $9K
80159 <1% 1,283 $9K
83527 <1% 3,704 $9K
87040 <1% 3,419 $9K
82340 <1% 5,689 $9K
81330 <1% 1,461 $8K
87328 <1% 2,713 $8K
87205 <1% 9,599 $8K
85247 <1% 1,015 $8K
82747 <1% 1,846 $8K
85613 <1% 5,851 $8K
86256 <1% 3,765 $8K
81422 <1% 2,289 $8K
80175 <1% 2,962 $8K
81244 <1% 1,798 $8K
81291 <1% 568 $8K
80185 <1% 3,852 $7K
84446 <1% 2,628 $7K
80183 <1% 2,209 $7K
82553 <1% 2,527 $7K
87425 <1% 1,641 $7K
83695 <1% 2,073 $7K
81260 <1% 1,816 $7K
80165 <1% 2,208 $7K
82164 <1% 2,931 $7K
87350 <1% 4,367 $7K
87496 <1% 588 $7K
81381 <1% 1,753 $7K
81332 <1% 348 $7K
87206 <1% 5,203 $7K
81290 <1% 1,464 $6K
86738 <1% 1,785 $6K
86682 <1% 5,558 $6K
81242 <1% 1,812 $6K
84238 <1% 305 $6K
86707 <1% 3,261 $6K
86060 <1% 5,302 $6K
86340 <1% 1,214 $6K
82166 <1% 702 $6K
83014 <1% 10,510 $6K
80366 <1% 21,368 $6K
83519 <1% 793 $6K
86671 <1% 2,300 $6K
88289 <1% 2,170 $6K
81406 <1% 236 $5K
82657 <1% 288 $5K
83625 <1% 2,026 $5K
81383 <1% 659 $5K
81256 <1% 200 $5K
82705 <1% 2,721 $5K
86148 <1% 942 $5K
82379 <1% 1,853 $5K
80195 <1% 1,193 $5K
80362 <1% 2,235 $5K
84597 <1% 649 $5K
84484 <1% 1,464 $5K
80326 <1% 19,465 $5K
82955 <1% 2,789 $5K
80341 <1% 20,300 $5K
G0475 Hiv antigen/antibody, combination assay, screening <1% 2,308 $5K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 1,527 $4K
87493 <1% 1,216 $4K
80337 <1% 19,652 $4K
80323 <1% 1,179 $4K
86308 <1% 4,009 $4K
80377 <1% 19,505 $4K
80360 <1% 20,098 $4K
80334 <1% 19,631 $4K
80184 <1% 2,141 $4K
82308 <1% 177 $4K
84378 <1% 3,446 $4K
80235 <1% 425 $4K
80321 <1% 1,218 $4K
80158 <1% 612 $4K
80357 <1% 19,513 $4K
83992 <1% 20,582 $4K
80368 <1% 20,608 $4K
80338 <1% 19,622 $4K
83605 <1% 1,986 $4K
80364 <1% 19,451 $4K
80145 <1% 267 $4K
86880 <1% 4,028 $4K
83003 <1% 1,403 $4K
80370 <1% 21,487 $4K
80367 <1% 20,208 $4K
82552 <1% 1,660 $4K
G0328 Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous <1% 10,680 $4K
84442 <1% 883 $3K
80371 <1% 19,438 $3K
83935 <1% 2,464 $3K
89055 <1% 5,793 $3K
80344 <1% 19,484 $3K
84143 <1% 556 $3K
83631 <1% 988 $3K
84255 <1% 345 $3K
80331 <1% 19,478 $3K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 305 $3K
80162 <1% 2,153 $3K
G0472 Hepatitis c antibody screening, for individual at high risk and other covered indication(s) <1% 4,315 $3K
85049 <1% 2,650 $3K
S3600 Stat laboratory request (situations other than s3601) <1% 1,327 $3K
84152 <1% 1,187 $3K
82642 <1% 371 $3K
80346 <1% 4,304 $3K
85670 <1% 4,056 $3K
83930 <1% 1,941 $3K
83789 <1% 396 $3K
81015 <1% 3,256 $3K
86005 <1% 3,847 $2K
0202U Oncology (prostate), multianalyte, gene expression profiling <1% 343 $2K
85300 <1% 1,706 $2K
83704 <1% 511 $2K
86036 <1% 843 $2K
83919 <1% 1,268 $2K
81206 <1% 131 $2K
85303 <1% 1,413 $2K
87116 <1% 955 $2K
81223 <1% 115 $2K
84300 <1% 3,082 $2K
G0145 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision <1% 7,684 $2K
87015 <1% 1,469 $2K
86615 <1% 33 $2K
84140 <1% 320 $2K
87807 <1% 1,014 $2K
82180 <1% 863 $2K
85302 <1% 833 $2K
88173 <1% 49 $2K
87420 <1% 349 $2K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 819 $2K
86631 <1% 497 $1K
82139 <1% 1,785 $1K
85305 <1% 783 $1K
80320 <1% 986 $1K
84202 <1% 1,020 $1K
80369 <1% 252 $1K
80201 <1% 236 $1K
81207 <1% 131 $1K
80355 <1% 20,854 $1K
82523 <1% 528 $1K
83825 <1% 263 $1K
84560 <1% 2,093 $1K
86316 <1% 187 $1K
82681 <1% 269 $1K
82175 <1% 176 $1K
84133 <1% 1,586 $1K
86804 <1% 529 $1K
84376 <1% 926 $1K
83986 <1% 1,877 $1K
81279 <1% 18 $1K
87230 <1% 136 $970.25
84163 <1% 1,236 $934.58
86215 <1% 140 $903.24
82436 <1% 960 $902.48
82530 <1% 138 $853.64
85230 <1% 106 $849.18
85250 <1% 117 $846.49
82384 <1% 173 $845.39
86022 <1% 55 $817.83
85732 <1% 3,982 $800.79
86606 <1% 72 $788.52
86794 <1% 1,103 $788.46
84433 <1% 26 $681.89
81401 <1% 151 $667.47
84252 <1% 92 $630.86
86161 <1% 74 $582.12
86352 <1% 27 $570.64
87076 <1% 287 $554.82
87102 <1% 625 $431.87
85301 <1% 359 $424.39
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 181 $417.43
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 59 $400.63
87486 <1% 705 $367.88
82540 <1% 192 $359.52
86790 <1% 128 $341.72
82656 <1% 782 $331.92
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 488 $312.97
0097U <1% 390 $307.05
85385 <1% 37 $302.95
80356 <1% 1,151 $293.19
87254 <1% 453 $265.98
80345 <1% 425 $264.50
80503 <1% 105 $264.19
84145 <1% 164 $259.82
82107 <1% 98 $249.57
87662 <1% 64 $245.63
80230 <1% 14 $244.29
85270 <1% 53 $243.96
88237 <1% 51 $232.89
G0306 Complete cbc, automated (hgb, hct, rbc, wbc, without platelet count) and automated wbc differential count <1% 916 $228.70
80168 <1% 28 $215.78
G0307 Complete (cbc), automated (hgb, hct, rbc, wbc; without platelet count) <1% 830 $195.94
87481 <1% 12 $183.41
80179 <1% 129 $171.19
87106 <1% 102 $163.09
86632 <1% 351 $160.97
85220 <1% 13 $160.74
85705 <1% 822 $140.17
87260 <1% 176 $134.93
87252 <1% 39 $132.74
87899 <1% 80 $120.84
86602 <1% 15 $117.89
83874 <1% 88 $116.48
82017 <1% 460 $116.15
87581 <1% 708 $105.25
87109 <1% 14 $102.77
80157 <1% 13 $86.82
84591 <1% 53 $72.75
0099U <1% 137 $59.19
86611 <1% 378 $54.84
87650 <1% 186 $46.31
83529 <1% 12 $40.95
86609 <1% 13 $38.65
86331 <1% 13 $35.95
G0124 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician <1% 320 $35.04
83945 <1% 17 $31.20
87279 <1% 176 $24.36
82608 <1% 119 $22.00
G0123 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision <1% 749 $19.62
86226 <1% 28 $18.30
80332 <1% 384 $11.89
87280 <1% 186 $6.64
89060 <1% 21 $5.22
84105 <1% 14 $3.12
86849 0% 14 $0.00
87275 0% 176 $0.00
99499 0% 193 $0.00
86703 0% 49 $0.00
87299 0% 176 $0.00
87905 0% 15 $0.00
81222 0% 103 $0.00
81405 0% 103 $0.00
80414 0% 14 $0.00
80374 0% 247 $0.00
87276 0% 176 $0.00
84585 0% 14 $0.00
84999 0% 13 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialWILLIAMS, KIMBERLY (VP)
Same official

Other billing entities under WILLIAMS, KIMBERLY

Full network →
ProviderLocationPaid
Laboratory Corporation of America HoldingsBurlington, NC$1.44B
Laboratory Corporation of America HoldingsRaritan, NJ$717.47M
Laboratory Corporation of America HoldingsDublin, OH$617.02M
Laboratory Corporation of America HoldingsBirmingham, AL$289.12M
Laboratory Corporation of AmericaPhoenix, AZ$265.90M
Laboratory Corporation of America HoldingsBurlington, NC$264.26M
Laboratory Corporation of America HoldingsCharleston, WV$220.04M
Laboratory Corporation of AmericaSeattle, WA$186.69M
Laboratory Corporation of AmericaSan Diego, CA$147.14M
Laboratory Corporation of AmericaHouston, TX$103.81M
Laboratory Corporation of AmericaEnglewood, CO$77.80M
Laboratory Corporation of AmericaDallas, TX$77.42M
Laboratory Corporation of AmericaBurlington, NC$59.75M
Medtox Laboratories, INCSaint Paul, MN$47.72M
Laboratory Corporation of America HoldingsBurlington, NC$15.65M
Laboratory Corporation of AmericaSan Antonio, TX$11.67M
Tri-Cities Laboratory, LLCKennewick, WA$8.69M
Laboratory Corporation of America HoldingsMonroe, LA$3.39M
Laboratory Corporation of AmericaItasca, IL$3.37M
Laboratory Corporation of AmericaAlbany, NY$2.06M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.